Abstract
Late preterm infants are defined as those born between 340/0 and 366/7 weeks of gestation. This population represents a growing proportion of preterm deliveries and traditionally has been neglected as thought to behave similarly to term infants. However, studies in the last decade have shown that they are vulnerable not only during the first few weeks of life but also later on in infancy and childhood. The aim of this review is to summarize the published literature in the field of the long-term outcomes of the late preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field. Continuous efforts should also be made so that the needs of these infants are recognized and managed in a timely appropriate manner.
Keywords: Late preterm, infants, long-term, outcome.
Current Pediatric Reviews
Title:Long-Term Outcome of Infants Born Late Preterm
Volume: 10 Issue: 4
Author(s): Despoina Gkentzi and Gabriel Dimitriou
Affiliation:
Keywords: Late preterm, infants, long-term, outcome.
Abstract: Late preterm infants are defined as those born between 340/0 and 366/7 weeks of gestation. This population represents a growing proportion of preterm deliveries and traditionally has been neglected as thought to behave similarly to term infants. However, studies in the last decade have shown that they are vulnerable not only during the first few weeks of life but also later on in infancy and childhood. The aim of this review is to summarize the published literature in the field of the long-term outcomes of the late preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field. Continuous efforts should also be made so that the needs of these infants are recognized and managed in a timely appropriate manner.
Export Options
About this article
Cite this article as:
Gkentzi Despoina and Dimitriou Gabriel, Long-Term Outcome of Infants Born Late Preterm, Current Pediatric Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573400510666141114224257
DOI https://dx.doi.org/10.2174/1573400510666141114224257 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Adenosine in Alzheimers Disease
Current Neuropharmacology Nutraceuticals in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) High-Level Expression and Purification of an Analgesic Peptide from Buthus martensii Karch
Protein & Peptide Letters Insulin Growth Factor-I Promotes Functional Recovery After a Focal Lesion in the Dentate Gyrus
CNS & Neurological Disorders - Drug Targets Effect of Neuroinflammation on ABC Transporters: Possible Contribution to Refractory Epilepsy
CNS & Neurological Disorders - Drug Targets The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology
Current Drug Targets - CNS & Neurological Disorders Commentary: Gut Microbiota and Brain Function: A New Target for Brain Diseases?
CNS & Neurological Disorders - Drug Targets Recent Advances of Fluorescent Technologies for Drug Discovery and Development
Current Pharmaceutical Design <i>Uncaria rhynchophylla</i> and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions
Current Vascular Pharmacology Erythropoietin: A Neuroprotective Agent in Cerebral Hypoxia, Neurodegeneration, and Epilepsy
Current Pharmaceutical Design The Quantitative Structure-Activity Relationships between GABAA Receptor and Ligands based on Binding Interface Characteristic
Current Computer-Aided Drug Design Role of Vitamins in Neurodegenerative Diseases: A Review
CNS & Neurological Disorders - Drug Targets An Appraisal of Current Pharmacological Perspectives of Sesamol: A Review
Mini-Reviews in Medicinal Chemistry Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders
Current Drug Targets Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site
Current Drug Targets Targeting Voltage-Gated Sodium Channels for Treating Neuropathic and Inflammatory Pain
Current Pharmaceutical Biotechnology Neurological Disorders of Purine and Pyrimidine Metabolism
Current Topics in Medicinal Chemistry α-Substituted Lactams and Acetamides: Ion Channel Modulators that Show Promise in Treating Drug-resistant Epilepsy
Central Nervous System Agents in Medicinal Chemistry Meldrum's Acid in Organic Synthesis, an Outlook to Reaction Media
Current Organic Chemistry HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research